The impact of tocilizumab treatment on the severity of inflammation and survival rates in sepsis is significantly influence by the timing of administration.


Creative Commons License

Tavaci T., Halici Z., Cadirci E., Ozkaraca M., Kasali K.

Inflammopharmacology, 2025 (SCI-Expanded, Scopus) identifier